Mayur Aalhate

550 total citations
35 papers, 378 citations indexed

About

Mayur Aalhate is a scholar working on Biomaterials, Molecular Biology and Pharmaceutical Science. According to data from OpenAlex, Mayur Aalhate has authored 35 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Biomaterials, 11 papers in Molecular Biology and 11 papers in Pharmaceutical Science. Recurrent topics in Mayur Aalhate's work include Nanoparticle-Based Drug Delivery (17 papers), Nanoplatforms for cancer theranostics (8 papers) and Drug Solubulity and Delivery Systems (7 papers). Mayur Aalhate is often cited by papers focused on Nanoparticle-Based Drug Delivery (17 papers), Nanoplatforms for cancer theranostics (8 papers) and Drug Solubulity and Delivery Systems (7 papers). Mayur Aalhate collaborates with scholars based in India, Australia and Malaysia. Mayur Aalhate's co-authors include Pankaj Kumar Singh, Srushti Mahajan, Ujala Gupta, Indrani Maji, Santosh Kumar Guru, R. Nair, Hoshiyar Singh, Neelesh Kumar Mehra, Rahul Kumar and Kamal Dua and has published in prestigious journals such as Journal of Controlled Release, Carbohydrate Polymers and Advances in Colloid and Interface Science.

In The Last Decade

Mayur Aalhate

30 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayur Aalhate India 14 169 116 108 89 34 35 378
Padakanti Sandeep Chary India 11 138 0.8× 100 0.9× 93 0.9× 75 0.8× 26 0.8× 31 337
Indrani Maji India 12 147 0.9× 104 0.9× 81 0.8× 137 1.5× 27 0.8× 30 376
Naveen Rajana India 13 146 0.9× 95 0.8× 101 0.9× 80 0.9× 24 0.7× 22 327
Ujala Gupta India 12 147 0.9× 101 0.9× 87 0.8× 78 0.9× 18 0.5× 30 309
Mara Perrone Italy 12 119 0.7× 131 1.1× 83 0.8× 138 1.6× 34 1.0× 15 402
Ganesh Vambhurkar India 14 184 1.1× 168 1.4× 152 1.4× 68 0.8× 33 1.0× 72 541
Srushti Mahajan India 15 253 1.5× 179 1.5× 173 1.6× 193 2.2× 63 1.9× 38 604
Aline de Cristo Soares Alves Brazil 11 142 0.8× 117 1.0× 88 0.8× 79 0.9× 22 0.6× 19 366
Sunil Kumar Yadava India 11 118 0.7× 106 0.9× 118 1.1× 109 1.2× 39 1.1× 16 358

Countries citing papers authored by Mayur Aalhate

Since Specialization
Citations

This map shows the geographic impact of Mayur Aalhate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayur Aalhate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayur Aalhate more than expected).

Fields of papers citing papers by Mayur Aalhate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayur Aalhate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayur Aalhate. The network helps show where Mayur Aalhate may publish in the future.

Co-authorship network of co-authors of Mayur Aalhate

This figure shows the co-authorship network connecting the top 25 collaborators of Mayur Aalhate. A scholar is included among the top collaborators of Mayur Aalhate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayur Aalhate. Mayur Aalhate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aalhate, Mayur, et al.. (2025). Solid supersaturated self-nanoemulsifying drug delivery system for abiraterone acetate: improved drug loading, dissolution, cellular uptake, and anticancer activity. Pharmaceutical Development and Technology. 30(5). 604–620. 1 indexed citations
2.
Aalhate, Mayur, et al.. (2025). Exploring the Potential of Nanocarriers for Cancer Immunotherapy: Insights into Mechanism, Nanocarriers, and Regulatory Perspectives. ACS Applied Bio Materials. 8(1). 108–138. 7 indexed citations
4.
Aalhate, Mayur, Srushti Mahajan, Pooja Yadav, et al.. (2025). Bovine serum albumin capped lipid nanosystem bearing CDK4/6 inhibitor to combat breast cancer: In-vitro and In-vivo assessment. International Journal of Biological Macromolecules. 333(Pt 2). 148873–148873.
5.
7.
Aalhate, Mayur, Srushti Mahajan, Indrani Maji, et al.. (2024). Unveiling multifaceted avenues of echogenic liposomes: Properties, preparation, and potential applications. Journal of Drug Delivery Science and Technology. 99. 105931–105931. 6 indexed citations
8.
Aalhate, Mayur, Srushti Mahajan, Hoshiyar Singh, et al.. (2024). Nano-enabled thermo-responsive local delivery of tamoxifen and carvacrol for enhanced anticancer action. Journal of Drug Delivery Science and Technology. 100. 106013–106013. 6 indexed citations
9.
Mahajan, Srushti, Mayur Aalhate, Rahul Kumar, et al.. (2024). Dasatinib loaded mucoadhesive lecithin-chitosan hybrid nanoparticles for its augmented oral delivery, in-vitro efficacy and safety. International Journal of Pharmaceutics. 651. 123784–123784. 18 indexed citations
11.
Gupta, Ujala, R. Nair, Mayur Aalhate, et al.. (2024). The Neoteric Paradigm of Biomolecule-Functionalized Albumin-Based Targeted Cancer Therapeutics. AAPS PharmSciTech. 25(8). 265–265. 1 indexed citations
12.
Maji, Indrani, Srushti Mahajan, Mayur Aalhate, et al.. (2024). Contemplating Novel W/O Emulsion Based Gel for Anti-Psoriatic Activity of Tofacitinib in Imiquimod-Induced Balb/C Mice Model. AAPS PharmSciTech. 26(1). 12–12.
13.
Aalhate, Mayur, et al.. (2024). Biohybrid nano-platforms manifesting effective cancer therapy: Fabrication, characterization, challenges and clinical perspective. Advances in Colloid and Interface Science. 335. 103331–103331. 7 indexed citations
14.
Gupta, Ujala, R. Nair, Mayur Aalhate, et al.. (2023). A comprehensive review of the biomaterial-based multifunctional nanocarriers for therapeutic applications in breast cancer. Journal of Drug Delivery Science and Technology. 89. 104990–104990. 14 indexed citations
15.
Mahajan, Srushti, Mayur Aalhate, Jitender Madan, et al.. (2023). Nanomedicine: A pragmatic approach for tackling melanoma skin cancer. Journal of Drug Delivery Science and Technology. 83. 104394–104394. 20 indexed citations
16.
Aalhate, Mayur, Srushti Mahajan, Hoshiyar Singh, Santosh Kumar Guru, & Pankaj Kumar Singh. (2023). Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer. Drug Delivery and Translational Research. 13(6). 1621–1653. 20 indexed citations
17.
Aalhate, Mayur, Srushti Mahajan, Hoshiyar Singh, et al.. (2023). Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-vitro, ex-vivo and in-vivo pharmacokinetic evaluation. Drug Delivery and Translational Research. 13(10). 2614–2638. 21 indexed citations
18.
Mahajan, Srushti, Mayur Aalhate, Indrani Maji, et al.. (2023). Core–Shell Type Lipidic and Polymeric Nanocapsules: the Transformative Multifaceted Delivery Systems. AAPS PharmSciTech. 24(1). 50–50. 31 indexed citations
19.
Mahajan, Srushti, Mayur Aalhate, Indrani Maji, et al.. (2023). Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer. Colloids and Surfaces B Biointerfaces. 233. 113631–113631. 25 indexed citations
20.
Mahajan, Srushti, Mayur Aalhate, Santosh Kumar Guru, & Pankaj Kumar Singh. (2022). Nanomedicine as a magic bullet for combating lymphoma. Journal of Controlled Release. 347. 211–236. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026